Gout

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Gout.php on line 2
Gout

LE WE PMID CA

Gout

998

Gicht

Febuxostat

Gout

Inflammasome

Pegloticase

Rasburicase

SLC2A9 GLUT9

URAT1

1972 1	Psychosomatic considerations in hyperuricemia and gout. [4552779] Psychosom Med 34(2): 165-82 (1972)
2006 2	Diagnosis and management of gout. [16740561] BMJ 332(7553): 1315-9 (2006)
1995 3	ABC of rheumatology. Gout, hyperuricaemia, and crystal arthritis. [7888900] BMJ 310(6978): 521-4 (1995)
2009 4	Gout--current diagnosis and treatment. [19795010] Dtsch Arztebl Int 106(34-35): 549-55 (2009)
2008 5	Febuxostat in the management of hyperuricemia and chronic gout: a review. [19337428] Ther Clin Risk Manag 4(6): 1209-20 (2008)
2006 6	EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). [16707533] Ann Rheum Dis 65(10): 1301-11 (2006)
2006 7	EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). [16707532] Ann Rheum Dis 65(10): 1312-24 (2006)
1980 8	Heberden oration 1979: human aberrations of purine metabolism and their significance for rheumatology. [6247984] Ann Rheum Dis 39(2): 103-17 (1980)
2009 9	Gout. Novel therapies for treatment of gout and hyperuricemia. [19664185] Arthritis Res Ther 11(4): 236 (2009)
2008 10	Developments in the scientific and clinical understanding of gout. [18947374] Arthritis Res Ther 10(5): 221 (2008)
2005 11	Clinical, humanistic, and economic outcomes of gout. [16300460] Am J Manag Care 11(15 Suppl): S459-64; quiz S465-8 (2005)
2005 12	Understanding treatments for gout. [16300459] Am J Manag Care 11(15 Suppl): S451-8; quiz S465-8 (2005)
2005 13	Diagnosis of gout: clinical, laboratory, and radiologic findings. [16300458] Am J Manag Care 11(15 Suppl): S443-50; quiz S465-8 (2005)
2005 14	Epidemiology of hyperuricemia and gout. [16300457] Am J Manag Care 11(15 Suppl): S435-42; quiz S465-8 (2005)
2005 15	Pathogenesis of gout. [16204163] Ann Intern Med 143(7): 499-516 (2005)
2009 16	Imaging of gout: findings and utility. [19591633] Arthritis Res Ther 11(3): 232 (2009)
2007 17	Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout? [17907217] Arthritis Rheum 57(7): 1324-8 (2007)
2007 18	The role of interleukin-1 and the inflammasome in gout: implications for therapy. [17907163] Arthritis Rheum 56(10): 3183-8 (2007)
2004 19	Gout: on the brink of novel therapeutic options for an ancient disease. [15334451] Arthritis Rheum 50(8): 2400-14 (2004)
2007 20	Assessment of outcome in clinical trials of gout--a review of current measures. [17650521] Rheumatology (Oxford) 46(12): 1751-6 (2007)
2007 21	British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. [17522099] Rheumatology (Oxford) 46(8): 1372-4 (2007)
2006 22	Effectiveness of interventions for the treatment of acute and prevention of recurrent gout--a systematic review. [16632483] Rheumatology (Oxford) 45(11): 1422-31 (2006)
2005 23	Mechanisms of inflammation in gout. [15956094] Rheumatology (Oxford) 44(9): 1090-6 (2005)
1999 24	Management of crystal arthritis. [10534540] Rheumatology (Oxford) 38(10): 912-6 (1999)
1975 25	Editorial: An evaluation of the pathogenesis of gouty kidney. [1099297] Kidney Int 8(2): 65-71 (1975)
1989 26	Crystal-associated arthropathies. [2538047] AJR Am J Roentgenol 152(4): 685-95 (1989)
2007 27	Why is gout so poorly managed? [17881662] Ann Rheum Dis 66(10): 1269-70 (2007)
2010 28	Advances in gout: some answers, more questions. [20959031] Arthritis Res Ther 12(5): 136 (2010)
2010 29	Mechanisms of inflammation in gout. [20441605] Arthritis Res Ther 12(2): 206 (2010)
2008 30	Gout in the spotlight. [18564404] Arthritis Res Ther 10(3): 112 (2008)
2010 31	How interleukin-1β induces gouty arthritis. [20662058] Arthritis Rheum 62(11): 3140-4 (2010)
2010 32	Interleukin-1 antagonism in acute gout: is targeting a single cytokine the answer? [20597109] Arthritis Rheum 62(10): 2845-9 (2010)
2008 33	Management of recurrent gout. [18258969] BMJ 336(7639): 329 (2008)
2008 34	The gout diagnosis. [18822471] Cleve Clin J Med 75 Suppl 5(-): S17-21 (2008)
2008 35	The practical management of gout. [18819330] Cleve Clin J Med 75 Suppl 5(-): S22-5 (2008)
2008 36	The pathogenesis of gout. [18822468] Cleve Clin J Med 75 Suppl 5(-): S2-4 (2008)
2008 37	Clinical manifestations of hyperuricemia and gout. [18822469] Cleve Clin J Med 75 Suppl 5(-): S5-8 (2008)
2006 38	Gout in 2006: the perfect storm. [17121496] Bull NYU Hosp Jt Dis 64(1-2): 82-6 (2006)
2010 39	Gout and its comorbidities. [20969552] Bull NYU Hosp Jt Dis 68(3): 199-203 (2010)
2007 40	Hyperuricemia and gout: new insights into pathogenesis and treatment. [17922673] Bull NYU Hosp Jt Dis 65(3): 215-21 (2007)
2008 41	Update on the management of hyperuricemia and gout. [18937638] Bull NYU Hosp Jt Dis 66(3): 231-9 (2008)
2009 42	Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout. [19109320] Rheumatology (Oxford) 48(3): 222-6 (2009)
2008 43	Hyperuricaemia--where nephrology meets rheumatology. [18443007] Rheumatology (Oxford) 47(7): 960-4 (2008)
2005 44	Diagnosis and management of gout: a rational approach. [16143687] Postgrad Med J 81(959): 572-9 (2005)
2009 45	Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal. [19846027] Health Technol Assess 13 Suppl 3(-): 37-42 (2009)
2008 46	Gout. [19445790] Clin Evid (Online) 2008(-): - (2008)
2010 47	Gout: a clinical syndrome illustrated and discussed. [20876915] Neth J Med 68(9): 352-9 (2010)
2007 48	Learning how and when to employ uricase as bridge therapy in refractory gout. [17924606] J Rheumatol 34(10): 1955-8 (2007)
2005 49	Gout: excess calories, purines, and alcohol intake and beyond. Response to a urate-lowering diet. [15868608] J Rheumatol 32(5): 773-7 (2005)
2009 50	Recent insights into the pathogenesis of hyperuricaemia and gout. [19808794] Hum Mol Genet 18(R2): R177-84 (2009)
2010 51	Management of hyperuricemia in gout: focus on febuxostat. [20169038] Clin Interv Aging 5(-): 7-18 (2010)
2010 52	New advances in the treatment of gout: review of pegloticase. [21127695] Ther Clin Risk Manag 6(-): 543-50 (2010)
2004 53	Gout: a review of its aetiology and treatment. [15299172] Hong Kong Med J 10(4): 261-70 (2004)
2010 54	Advances in the management of gout: critical appraisal of febuxostat in the control of hyperuricemia. [21694922] Int J Nephrol Renovasc Dis 3(-): 1-10 (2010)
2011 55	Revisiting the pathogenesis of podagra: why does gout target the foot? [21569453] J Foot Ankle Res 4(1): 13 (2011)
2011 56	The role of the NLRP3 inflammasome in gout. [22096368] J Inflamm Res 4(-): 39-49 (2011)
2010 57	"Clinical features of women with gout arthritis." A systematic review. [20084441] Clin Rheumatol 29(6): 575-82 (2010)
2010 58	Managing gout: how is it different in patients with chronic kidney disease? [21147946] Cleve Clin J Med 77(12): 919-28 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Gout.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Gout.php on line 92